《通过NO调节人T淋巴细胞内HIV的复制》

  • 来源专题:艾滋病防治
  • 编译者: 李越
  • 发布时间:2005-04-16
  • Addition of nitric oxide (NO) donors to mitogen-activated human immunodeficiency virus type 1 (HIV-1)-infected peripheral blood mononuclear cultures produced a significant increase in virus replication, and this effect was not associated with a change in cell proliferation. This effect was only observed with T-tropic X4 or X4R5 virus but not with R5 virus. Moreover, HIV-1 replication in mitogen-stimulated cultures was partially prevented by the specific inhibitors of the inducible nitric oxide synthase (iNOS). NO donors also enhanced HIV-1 infection of the human T-cell lines, Jurkat and MT-2. We have also observed that NO leads to an enhancement of HIV-1 replication in resting human T cells transfected with a plasmid carrying the entire HIV-1 genome and activated with phorbol ester plus ionomycin. Thus, in those cultures NO donors strongly potentiated HIV-1 replication in a dose-dependent manner, up to levels comparable to those with tumor necrosis factor alpha (TNF-α) stimulation. Furthermore, iNOS inhibitors decreased HIV-1 replication in HIV-1-transfected T cells to levels similar to those obtained with neutralizing anti-TNF-α antibodies. Moreover, HIV-1 replication induced iNOS and TNF-α transcription in T cells and T-cell lines. Interestingly, NO donors also stimulated long terminal repeat (LTR)-driven transcription whereas iNOS inhibitors partially blocked TNF-α-induced LTR transcription. Therefore, our results suggest that NO is involved in HIV-1 replication, especially that induced by TNF
  • 原文来源:http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=114219
相关报告
  • 《HIV-1诱导产生的 GRO刺激HIV-1在巨噬细胞和T淋巴细胞内的复制》

    • 来源专题:艾滋病防治
    • 编译者:李越
    • 发布时间:2005-04-16
    • We examined the early effects of infection by CCR5-using (R5 human immunodeficiency virus [HIV]) and CXCR4-using (X4 HIV) strains of HIV type 1 (HIV-1) on chemokine production by primary human monocyte-derived macrophages (MDM). While R5 HIV, but not X4 HIV, replicated in MDM, we found that the production of the C-X-C chemokine growth-regulated oncogene alpha (GRO-) was markedly stimulated by X4 HIV and, to a much lesser extent, by R5 HIV. HIV-1 gp120 engagement of CXCR4 initiated the stimulation of GRO- production, an effect blocked by antibodies to CXCR4. GRO- then fed back and stimulated HIV-1 replication in both MDM and lymphocytes, and antibodies that neutralize GRO- or CXCR2 (the receptor for GRO-) markedly reduced viral replication in MDM and peripheral blood mononuclear cells. Therefore, activation of MDM by HIV-1 gp120 engagement of CXCR4 initiates an autocrine-paracrine loop that may be important in disease progression after the emergence of X4 HIV.
  • 《Adv Mater | 新型PDC药物抑制内皮细胞介导的T淋巴细胞凋亡》

    • 来源专题:生物安全知识资源中心—领域情报网
    • 编译者:hujm
    • 发布时间:2023-10-23
    •  血管新生是肿瘤进展的标志性事件,与诸多癌症的不良预后相关。其中,肿瘤相关内皮细胞(TECs)通过上调其Fas配体(FasL)表达诱导肿瘤浸润T淋巴细胞凋亡是一个重要原因。因此,下调TECs的FasL表达是潜在的肿瘤免疫治疗策略。   2023年10月17日,上海药物所李亚平团队与上海科技大学张鹏程团队联合在Advanced Materials上发表了题为“Inhibiting endothelial cell-mediated T lymphocyte apoptosis with integrin-targeting peptide-drug conjugate filaments for chemoimmunotherapy of triple-negative breast cancer”的研究论文。该研究构建了由多肽-药物偶联物(PDC)自组装形成的多肽纳米纤维,通过协同调控TECs和肿瘤细胞,缓解TECs介导的T淋巴细胞功能障碍,提高三阴性乳腺癌(TNBC)的治疗效果。   研究人员利用谷胱甘肽响应性linker分子将7-乙基-10-羟基喜树碱(SN38)与羧基端带有Arg-Gly-Asp-Arg(RGDR)或His-Lys-Asp(HKD)序列的亲水多肽偶联,获得了SN38-HKD和SN38-RGDR两种PDC,接着利用共组装技术,筛选SN38-RGDR用量,得到了具有最佳TNBC细胞和TECs靶向能力的多肽纤维SN38-HKD/RGDR。  研究表明,SN38-HKD/RGDR通过减少TECs的前列腺素E2(PGE2),降低骨髓来源巨噬细胞和肿瘤细胞的血管内皮生长因子(VEGF)和白介素10(IL-10)的水平,从而协同下调TECs的FasL表达。   进一步研究发现,SN38-HKD/RGDR降低了肿瘤内PGE2、VEGF和IL-10三种因子的水平,进而协同下调TECs的FasL表达,减少FasL介导的浸润T淋巴细胞凋亡。此外,SN38-HKD/RGDR还具有诱导肿瘤细胞免疫原性细胞死亡的活性,激活抗肿瘤免疫。SN38-HKD/RGDR的两种作用机制协同,增加了瘤内CD8+ T细胞的浸润和活力,抑制了原发瘤生长和肿瘤肺转移。   上海药物所李亚平研究员和上海科技大学张鹏程研究员为本文的共同通讯作者,上海药物所博士研究生蔡颖和硕士研究生朱彬毓为本文共同第一作者。该研究得到了国家重点研发计划、国家自然科学基金、中国科学院等项目的资助。   全文链接:https://doi.org/10.1002/adma.202306676